Opis

• Tytuł:
  Tirzepatide - role in obesity, health and physical wellness. Information overview
• Twórca:
  Hanslik, Anna;
  Mendak, Magdalena;
  Białek, Agata;
  Walczak, Agnieszka;
  Hovagimyan, Adrian;
  Olszanecka, Monika;
  Olszanecki, Tomasz
• Opis:
  Nowadays there is an increasing number of people with overweight and obesity all around the world. Unhealthy food, sweets and fast foods are available everywhere, that causes self-perpetuating problem. Food restriction is an obvious treatment, but it is difficult to achieve. A certain solution are GLP-1 agonists using to treat type 2 diabetes. Last studies shown that that medicaments may be effective in promoting weight loss. Tirzepatide as a novelty and is a long-acting dual agonist of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. It can be very supportive in the fight against obesity.
• Dostępność obiektu:
  Dostęp otwarty
• Prawa:
  Prawa autorskie (c) 2025 Anna Hanslik, Magdalena Mendak, Agata Białek, Agnieszka Walczak, Adrian Hovagimyan, Monika Olszanecka, Tomasz Olszanecki;
  https://creativecommons.org/licenses/by-nc-sa/4.0
• Data:
  2025.02.13
• Typ:
  info:eu-repo/semantics/article;
  info:eu-repo/semantics/publishedVersion
• Język:
  angielski
• Źródło:
  Quality in Sport; Tom 38 (2025); 58191;
  Quality in Sport; Vol. 38 (2025); 58191;
  2450-3118
• Format:
  application/pdf
• Wydawca:
  University Center for Sports Research, Nicolaus Copernicus University, Torun, Poland
• Relacja: https://apcz.umk.pl/QS/article/view/58191/41528
• Temat i słowa kluczowe:
  Tirzepatide;
  GLP-1;
  GIP;
  GIP/GLP-1 dual agonist;
  Obesity;
  Diabetes Mellitus type 2;
  SURMOUNT;
  FDA;
  EMA
• Identyfikator: https://apcz.umk.pl/QS/article/view/58191
• Dostawca danych:
  Akademicka Platforma Czasopism
• Czy mogę z tego obiektu skorzystać?:
  poproś o pozwolenie
• Rodzaj zawartości:
  teksty